Important: Gros-100 is a prescription anticancer medicine containing paclitaxel. It is administered intravenously by qualified healthcare professionals as part of an oncology treatment plan. The information below is for education and should not replace advice from an oncologist.

What is Gros-100 Injection?

Gros-100 Injection contains paclitaxel, a chemotherapy medicine belonging to the taxane class of anticancer drugs. The product shown is a 100 mg/16.7 mL formulation marketed by Emcure Pharmaceuticals Ltd. Official Indian pricing documentation also lists Gros 100 mg/16.7 mL as a paclitaxel injection manufactured by Emcure Pharmaceuticals Ltd.

Paclitaxel works by interfering with microtubules, structures that cells need during cell division. It stabilizes these structures and prevents their normal breakdown, disrupting the process by which rapidly dividing cells reproduce. This can stop cancer cells from multiplying and eventually lead to their death.

Paclitaxel is used in several chemotherapy treatment plans, including certain cases of breast cancer, ovarian cancer, non-small cell lung cancer, and AIDS-related Kaposi sarcoma. Depending on the cancer and treatment plan, it may be used alone or together with other anticancer medicines.

Because Gros-100 is an intravenous chemotherapy medicine, it should only be administered under appropriate medical supervision.

Uses of Gros-100 Injection

Paclitaxel is an established chemotherapy medicine used for selected cancers. The exact indication depends on the cancer type, stage, previous treatments, and the overall treatment plan.

Common medically recognized uses include:

• Treatment of certain types of breast cancer
• Treatment of advanced ovarian cancer
• Treatment of certain non-small cell lung cancers
• Treatment of AIDS-related Kaposi sarcoma in appropriate circumstances
• Use as part of combination chemotherapy regimens when recommended by an oncology specialist

Gros-100 should only be administered under the supervision of a qualified healthcare professional.

Benefits of Gros-100 Injection

The potential benefits of paclitaxel relate to its ability to interfere with cancer-cell division. It is not a general-purpose medicine and is used only when considered appropriate for a specific cancer treatment plan.

Potential treatment benefits include:

• Helps inhibit the multiplication of cancer cells
• Can contribute to controlling tumour growth in appropriate cancers
• Can be combined with other anticancer medicines in established treatment regimens
• Provides an established taxane chemotherapy option for selected malignancies
• May contribute to disease control when incorporated into an appropriate oncology treatment plan

The response to treatment varies considerably between individuals. Paclitaxel should not be considered a guaranteed cure, and treatment outcomes depend on factors such as cancer type, stage, previous treatment, and overall health.

How Does Gros-100 Work?

Paclitaxel targets microtubules, which are important structures inside cells. During normal cell division, microtubules need to assemble and disassemble in a controlled way so chromosomes can be separated correctly.

Paclitaxel binds to tubulin and promotes stabilization of microtubules. This prevents their normal disassembly and interferes with mitosis, the process of cell division. Cancer cells that are actively dividing can therefore be prevented from continuing to multiply.

This action is also responsible for some of the medicine’s adverse effects because chemotherapy can affect certain healthy cells that divide relatively quickly.

How is Gros-100 Injection Given?

Gros-100 is an intravenous chemotherapy medicine and is not intended for self-administration.

The treatment schedule, dose, infusion procedure, and number of treatment cycles are determined individually by the treating oncology team. These decisions depend on the cancer being treated, other medicines being used, laboratory results, organ function, and the patient’s response to treatment.

Patients should:

• Receive the medicine only through qualified healthcare professionals.
• Follow the treatment plan provided by their oncology team.
• Inform the medical team about any new or worsening symptoms.
• Never change, repeat, or discontinue chemotherapy treatment without medical advice.
• Tell the healthcare team about all medicines, supplements, and medical conditions before treatment.

Because paclitaxel treatment requires professional monitoring, specific dosing instructions should come directly from the treating oncologist.

Gros-100 Injection Side Effects

Like all medicines, Gros-100 Injection may cause side effects, although not everyone experiences them. Cancer treatment side effects can vary from person to person.

Common Side Effects

Possible side effects associated with paclitaxel include:

• Hair loss
• Nausea or vomiting
• Diarrhea or constipation
• Tiredness or weakness
• Muscle or joint pain
• Changes in blood-cell counts
• Peripheral neuropathy, such as tingling or numbness
• Appetite changes
• Injection or infusion-related reactions

Paclitaxel is also associated with muscle and joint pain in some patients, which may occur after treatment.

Serious Side Effects

Seek prompt medical attention for symptoms that may indicate a serious reaction, such as:

• Difficulty breathing or significant swelling
• Severe allergic or infusion-related reaction
• Fever or signs of infection
• Unusual bleeding or bruising
• Severe weakness
• Significant numbness, tingling, or other nerve symptoms
• Chest pain, fainting, or significant changes in heartbeat
• Severe or persistent symptoms following treatment

Paclitaxel can cause bone-marrow suppression, which can reduce blood-cell counts and increase the risk of infection or bleeding. Medical teams therefore monitor blood counts during treatment.

If side effects persist or become severe, contact your healthcare provider promptly.

Warnings and Precautions

Before treatment with Gros-100, the oncology team should know about existing medical conditions and previous reactions to chemotherapy.

Pregnancy

Paclitaxel may cause fetal harm. Patients who are pregnant, planning pregnancy, or who could become pregnant should discuss this with their healthcare professional before treatment.

Breastfeeding

Breastfeeding may need to be avoided during paclitaxel treatment because the medicine may pose a risk to a nursing infant. The treating physician should provide individualized guidance.

Liver Problems

Liver function is important when considering paclitaxel treatment. Patients with liver disease should inform their doctor because impaired liver function can affect the handling of the medicine.

Heart Conditions

Patients with existing heart problems, abnormal heart rhythms, or previous cardiac complications should tell their healthcare team. Paclitaxel can occasionally be associated with cardiovascular or rhythm-related effects.

Allergies

Tell the medical team about any previous allergy or serious reaction to paclitaxel or any component of the formulation. Serious hypersensitivity reactions can occur.

Elderly Patients

Older adults may require careful assessment because they can be more vulnerable to certain chemotherapy-related adverse effects.

Driving and Machinery

Fatigue, dizziness, weakness, or other treatment-related effects may affect alertness. Patients should follow their healthcare professional’s advice regarding driving or operating machinery.

Drug Interactions

Paclitaxel can interact with other medicines. Its metabolism involves the CYP2C8 and CYP3A4 enzyme systems, so medicines that inhibit or induce these pathways may affect paclitaxel exposure.

Before receiving Gros-100, tell the oncology team about:

• Prescription medicines
• Over-the-counter medicines
• Antibiotics and antifungal medicines
• Medicines used for seizures or other neurological conditions
• Vitamins and mineral supplements
• Herbal or traditional medicines
• Other cancer treatments

Certain chemotherapy combinations can also influence toxicity or drug levels, so the treatment sequence and combination should be determined by the oncology team.

Storage Instructions

Gros-100 is a professional-use injectable medicine. Storage and handling should follow the manufacturer’s product instructions and institutional oncology protocols.

General precautions include:

• Keep the product in its original packaging until required.
• Protect it according to the manufacturer’s specified storage conditions.
• Do not use a vial that is damaged or expired.
• Keep medicines away from children and unauthorized users.
• Preparation and disposal should be handled by trained healthcare personnel according to applicable medical and hazardous-drug procedures.

Gros-100 Price and Availability

The price of Gros-100 Injection can vary according to location, applicable regulations, pharmacy or hospital charges, and changes in official pricing. Because this is a prescription chemotherapy medicine, purchasing decisions and treatment should be handled through an appropriate healthcare provider and licensed pharmacy.

For safety reasons, this article does not provide instructions for purchasing or self-administering the medicine.

Disclaimer

This Gros-100 Injection product description is provided for educational and informational purposes only. It is not a substitute for medical advice, diagnosis, or treatment.

Gros-100 contains paclitaxel, a potent anticancer medicine that requires professional supervision. Do not self-medicate or attempt to administer this injection yourself. Treatment decisions, including the appropriate regimen and dose, must be made by a qualified oncology professional based on the individual patient’s condition.

Individual responses to chemotherapy can vary. Always follow the prescription and instructions provided by your healthcare team.

Frequently Asked Questions

1. What is Gros-100 Injection used for?

Gros-100 contains paclitaxel, a taxane chemotherapy medicine. It is used in selected cancer treatment plans, including certain breast, ovarian, and non-small cell lung cancers and AIDS-related Kaposi sarcoma. The exact use depends on the patient’s diagnosis and treatment plan.

2. How does Gros-100 work?

Paclitaxel interferes with microtubules, structures required for normal cell division. By stabilizing microtubules and disrupting mitosis, it prevents rapidly dividing cancer cells from completing normal cell division and can ultimately cause cancer-cell death.

3. Is Gros-100 safe?

Paclitaxel can be an appropriate treatment when prescribed for a suitable cancer and administered with proper monitoring. However, it can cause significant adverse effects, including reduced blood-cell counts, nerve problems, and infusion-related reactions. Safety depends on the individual’s health and treatment plan.

4. Can Gros-100 be used for long-term treatment?

The duration of paclitaxel treatment varies according to the cancer type, treatment regimen, response, and tolerance. Some patients receive multiple treatment cycles, while others may require a different plan. The treating oncologist decides how long treatment should continue.

5. What happens if a scheduled treatment is missed?

Patients should not try to compensate for a missed chemotherapy treatment themselves. Contact the oncology team as soon as possible so they can determine the appropriate next step and whether the treatment schedule needs adjustment.

6. Can Gros-100 be stopped suddenly?

Paclitaxel is administered as part of a planned chemotherapy regimen. Patients should not independently stop, postpone, or alter their treatment. Any change should be discussed with the treating oncologist, who can weigh the benefits and risks of continuing treatment.

7. Can Gros-100 be taken with food?

Gros-100 is an intravenous medicine rather than an oral tablet or capsule, so food does not determine how the medicine is administered. Patients should follow the dietary and medication instructions provided by their oncology team.

8. What are the common Gros-100 side effects?

Commonly reported effects associated with paclitaxel include hair loss, nausea, vomiting, fatigue, muscle or joint pain, changes in blood-cell counts, and peripheral neuropathy. Side effects vary between patients, and the healthcare team can provide supportive treatment when appropriate.

9. Who should avoid Gros-100?

Paclitaxel may not be appropriate for everyone. The oncology team needs to consider factors such as previous serious hypersensitivity reactions, blood-cell counts, liver function, pregnancy, and other medical conditions. Patients should provide a complete medical history before treatment.

10. How should Gros-100 be stored?

Gros-100 is a professional-use injectable medicine. It should be stored and handled according to the manufacturer’s instructions and healthcare-facility protocols. Patients should not attempt to prepare, store, or administer the medicine independently.